Search details
1.
Impact of muscle biopsy on the clinical decision-making process in patients with suspected idiopathic inflammatory myopathy.
J Autoimmun
; 144: 103185, 2024 04.
Article
in English
| MEDLINE | ID: mdl-38428109
2.
Multiparametric Prediction Models for Coronavirus Disease 2019 Vaccine Selection: Results of a Comparative Population-Based Cohort Study.
Clin Infect Dis
; 76(5): 816-823, 2023 03 04.
Article
in English
| MEDLINE | ID: mdl-36328594
3.
Safety and immunogenicity of a third COVID-19 vaccination in patients with immune-mediated inflammatory diseases compared with healthy controls.
Ann Rheum Dis
; 82(2): 292-300, 2023 Feb.
Article
in English
| MEDLINE | ID: mdl-36109141
4.
Accelerated waning of immune responses to a third COVID-19 vaccination in patients with immune-mediated inflammatory diseases.
J Autoimmun
; 135: 102981, 2023 02.
Article
in English
| MEDLINE | ID: mdl-36706534
5.
Tocilizumab in patients with new onset polymyalgia rheumatica (PMR-SPARE): a phase 2/3 randomised controlled trial.
Ann Rheum Dis
; 81(6): 838-844, 2022 06.
Article
in English
| MEDLINE | ID: mdl-35210264
6.
Importance of the second SARS-CoV-2 vaccination dose for achieving serological response in patients with rheumatoid arthritis and seronegative spondyloarthritis.
Ann Rheum Dis
; 81(3): 416-421, 2022 03.
Article
in English
| MEDLINE | ID: mdl-34844927
7.
Response to SARS-CoV-2 vaccination in systemic autoimmune rheumatic disease depends on immunosuppressive regimen: a matched, prospective cohort study.
Ann Rheum Dis
; 81(7): 1017-1022, 2022 07.
Article
in English
| MEDLINE | ID: mdl-35304407
8.
Immunogenicity and safety of a fourth COVID-19 vaccination in rituximab-treated patients: an open-label extension study.
Ann Rheum Dis
; 81(12): 1750-1756, 2022 12.
Article
in English
| MEDLINE | ID: mdl-35977809
9.
Additional heterologous versus homologous booster vaccination in immunosuppressed patients without SARS-CoV-2 antibody seroconversion after primary mRNA vaccination: a randomised controlled trial.
Ann Rheum Dis
; 81(5): 687-694, 2022 05.
Article
in English
| MEDLINE | ID: mdl-35027397
10.
SARS-CoV-2 vaccination in rituximab-treated patients: B cells promote humoral immune responses in the presence of T-cell-mediated immunity.
Ann Rheum Dis
; 80(10): 1345-1350, 2021 10.
Article
in English
| MEDLINE | ID: mdl-34285048
11.
SARS-CoV-2 vaccination in rituximab-treated patients: evidence for impaired humoral but inducible cellular immune response.
Ann Rheum Dis
; 80(10): 1355-1356, 2021 10.
Article
in English
| MEDLINE | ID: mdl-33958323
12.
FAPi PET/CT for assessment and visualisation of active myositis-related interstitial lung disease: a prospective observational pilot study.
EClinicalMedicine
; 72: 102598, 2024 Jun.
Article
in English
| MEDLINE | ID: mdl-38633577
13.
Neuropsychiatric Systemic Lupus Erythematosus: A Remaining Challenge.
Curr Pharm Des
; 28(11): 881-891, 2022.
Article
in English
| MEDLINE | ID: mdl-35549864
14.
Lipoprotein (a) and long-term outcome in patients with peripheral artery disease undergoing revascularization.
Atherosclerosis
; 363: 94-101, 2022 Dec.
Article
in English
| MEDLINE | ID: mdl-36280470
15.
Reactogenicity and immunogenicity of the second COVID-19 vaccination in patients with inborn errors of immunity or mannan-binding lectin deficiency.
Front Immunol
; 13: 974987, 2022.
Article
in English
| MEDLINE | ID: mdl-36189225
16.
Heterologous vector versus homologous mRNA COVID-19 booster vaccination in non-seroconverted immunosuppressed patients: a randomized controlled trial.
Nat Commun
; 13(1): 5362, 2022 09 12.
Article
in English
| MEDLINE | ID: mdl-36097029
17.
Evaluation of sCD163 and sTWEAK in patients with stable peripheral arterial disease and association with disease severity as well as long-term mortality.
Atherosclerosis
; 317: 41-46, 2021 01.
Article
in English
| MEDLINE | ID: mdl-33378730
18.
GlycA for long-term outcome in T2DM secondary prevention.
Diabetes Res Clin Pract
; 171: 108583, 2021 Jan.
Article
in English
| MEDLINE | ID: mdl-33307129
Results
1 -
18
de 18
1
Next >
>>